To hear about similar clinical trials, please enter your email below
Trial Title:
Insights Into Participating in Studies for Bone Cancer
NCT ID:
NCT06070259
Condition:
Bone Cancer
Conditions: Official terms:
Bone Neoplasms
Osteosarcoma
Conditions: Keywords:
Bone Cancer
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Clinical studies, with a distinct focus on bone cancer, play a crucial role in evaluating
the safety and effectiveness of novel treatments for this disease. These trials serve as
instrumental means to determine whether new medications surpass conventional therapies,
providing substantial evidence for their broader adoption.
The primary objective is to meticulously scrutinize trial completion rates and voluntary
withdrawals within this specific patient group.
Criteria for eligibility:
Study pop:
Bone cancer patients who are actively considering enrolling in a clinical trial for the
said condition, but have not yet completed enrollment and randomization phases.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Aged ≥ 18 years old and ability to provide written informed consent obtained prior
to participation in the study and any related procedures being performed
- Diagnosis of bone cancer
- No prior treatment for bone cancer
Exclusion Criteria:
- Has known psychiatric or substance abuse disorders that would interfere with
cooperation with the requirements of the trial
- Enrolled in another research study
- Inability to provide written informed consent
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Power Life Sciences
Address:
City:
San Francisco
Zip:
94107
Country:
United States
Contact:
Last name:
Michael B Gill
Phone:
415-900-4227
Email:
https://www.withpower.com/contact-us@withpower.com
Start date:
October 2024
Completion date:
October 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06070259
